Vimarsana
Biggest News Aggregation in the World

Michael Lincoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Lincoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Lincoff Today - Breaking & Trending Today

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions - Vimarsana News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

A SELECT investigator says he continues to believe the drugs are safe. The agency says it will keep watch for signals.

Source: tctmd.com
Who Benefits Most from Semaglutide and How Long Will That Take? - Vimarsana News

Who Benefits Most from Semaglutide and How Long Will That Take?

There are no easy answers based on the SELECT data seen so far, leaving physicians to think hard about underlying risks and costs.

Source: tctmd.com
Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes - Vimarsana News

Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes

Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity

Study shows weight loss drug may also cut heart attack risk - Vimarsana News

Study shows weight loss drug may also cut heart attack risk

A study by Cleveland Clinic Dr. Michael Lincoff shows that semaglutide, a drug found in Ozempic, may also cut heart attack risk.

Source: khou.com
Diabetes Drug Could Help Reduce Risk for Cardiovascular Events, Study Finds - Vimarsana News

Diabetes Drug Could Help Reduce Risk for Cardiovascular Events, Study Finds

Semaglutide, which is a popular drug used to treat diabetes, could soon have another use. Cleveland Clinic researchers found it may also be able to reduce the risk of cardiovascular